Related Experiment Video
Updated: Jul 15, 2026

09:50
A Single Cell Dissociation Approach for Molecular Analysis of Urinary Bladder in the Mouse Following Spinal Cord Injury
Published on: June 17, 2020
Urinary Biomarkers for Screening High-Risk Urodynamic Phenotypes in Early Spinal Cord Injury: A Pilot Study
Catherine Forster1, Danira Garcia Gutierrez2, Rose Khavari3
1University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Neurourology and Urodynamics
|July 14, 2026
Summary
Urinary biomarkers can identify high-risk neurogenic bladder (NB) phenotypes early after spinal cord injury (SCI). This noninvasive approach aids in early risk stratification and targeted urodynamic studies (UDS) use.
Area of Science:
- Urology
- Nephrology
- Neurology
Background:
- Neurogenic bladder (NB) following spinal cord injury (SCI) presents significant morbidity.
- Early characterization of NB post-SCI is limited due to challenges with standard urodynamic studies (UDS).
- Developing noninvasive methods to assess bladder function early after SCI is crucial.
Purpose of the Study:
- To evaluate the potential of urinary biomarkers for identifying high-risk bladder phenotypes in acute SCI.
- To assess the diagnostic performance of individual and panel-based biomarkers.
- To determine if biomarkers can aid in early risk stratification for NB.
Main Methods:
- Prospective cohort study of 45 individuals with acute SCI (≤6 weeks).
- Analysis of nine urinary biomarkers using ELISA in catheter-dependent participants and controls.
- Urodynamic studies (UDS) performed on 35 participants to define high-risk bladder phenotypes (DO, DSD, elevated detrusor pressure, low compliance).
Main Results:
- Individual biomarkers showed moderate discrimination for specific high-risk phenotypes (e.g., NGAL for DO/DSD, RANTES/CCL5 for elevated detrusor pressure).
- A multivariable biomarker panel demonstrated improved detection of high-risk bladder (AUC 0.73).
- The panel achieved high sensitivity (0.94) and negative predictive value (0.92) at an optimized threshold.
Conclusions:
- Urinary biomarkers show promise for noninvasively identifying individuals with early SCI at risk for adverse urodynamic findings.
- This approach could facilitate earlier risk stratification and guide the selective use of UDS in rehabilitation.
- Further validation in larger studies is necessary to establish the clinical utility of these biomarkers.
